Latest Peripheral vascular disease Stories
The global market for peripheral vascular surgical devices was valued at $5.8 billion in 2012 and at $6.2 billion for 2013.
PLEASANTON, Calif., and SINGAPORE, Feb.
System Provides Physicians New Option for Treating Complete Blockages in the Major Arteries of the Leg NATICK, Mass., Feb.
MENLO PARK, Calif., Jan.
A multicenter study that previously reported a reduction in heart attack and stroke with a Mediterranean diet supplemented with extra-virgin olive oil or with nuts now also reports a lower risk of peripheral artery disease
Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm).
Siragusa Vein and Vascular Center posts a new article outlining the gravity of vein disease and the importance of vein screening for overall health. (PRWEB)